Sat.Feb 18, 2023 - Fri.Feb 24, 2023

article thumbnail

Digital Therapies: The “Digital Pills” of current generation

Roots Analysis

As per United Nation’s report, the current global population stands at around 8 billion and expected to reach 9 billion by the end of 2030. This increase in population is accompanied with a rise in the incidence of several chronic disease indications. In fact, as per a report published by National Association of Chronic Disease Director , by 2030 this increase of the chronic condition would cost the US economy about USD 2 trillion.

52
article thumbnail

Holding pharmacy benefit managers accountable

PhRMA

State legislative sessions across the country are in full swing, and many state officials have made lowering the cost of medicine for patients a top priority. If policymakers are serious about addressing high out-of-pocket costs for patients, they should start by taking steps to finally hold pharmacy benefit managers (PBMs) accountable.

Insurance 277
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amoxicillin Shortage Impacting Nearly 75% of Pharmacists Nationwide

Drug Topics

Pharmacists generally agree that domestic production of the commonly used antibiotic could prevent more shortages from happening in the future

187
187
article thumbnail

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license

Fierce Pharma

Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18

Vaccines 145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Major coalition of health groups aims to combat health misinformation

Fierce Healthcare

Major coalition of health groups aims to combat health misinformation rking Fri, 02/24/2023 - 11:17

145
145
article thumbnail

What they are saying: Nonprofit hospitals are gaming the system at the expense of patients

PhRMA

There have been some alarming stories uncovered by the media on ways nonprofit hospitals — many of which participate in the 340B drug pricing program — are taking advantage of the system and their tax-exempt status to boost their bottom lines, at the expense of patients.

Hospitals 231

More Trending

article thumbnail

STAT+: How a depression test devised by a Zoloft marketer became a crutch for a failing mental health system

STAT

A bedrock of the U.S. mental health system — a nine-item questionnaire used to spot depression — began not with a doctor, but with a marketing man. Howard Kroplick, now 73 years old and living on Long Island, is obsessed with antique racing cars and, in his storied career in the pharmaceutical industry, crucially urged Pfizer to avoid the word “impotence” when promoting Viagra.

139
139
article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabin

article thumbnail

PhRMA submits comments to USPTO highlighting important role of patent system in medicine development

PhRMA

PhRMA responded to the U.S. Patent and Trademark Office’s (USPTO) request for comments regarding USPTO initiatives to ensure the robustness and reliability of patent rights.

225
225
article thumbnail

FDA Action Date Set for Pfizer RSV Vaccine Candidate

Drug Topics

The vaccine would be administered to pregnant people to protect newborns from RSV.

Vaccines 187
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Google, Microsoft execs share how racial bias can hinder expansion of health AI

Fierce Healthcare

Google, Microsoft execs share how racial bias can hinder expansion of health AI rking Thu, 02/23/2023 - 12:36

131
131
article thumbnail

First successful CAR-T treatment for muscle inflammation

European Pharmaceutical Review

University Hospital Erlangen in Germany is the first in the world to use chimeric antigen receptor (CAR) T-cells to successfully treat a patient suffering from a severe case of muscle inflammation (myositis). The researchers noted that risk of developing a very severe form of the autoimmune inflammatory disease is high. The patient who received the CAR T treatment was diagnosed with anti-synthetase syndrome.

article thumbnail

Stopping pharmacy benefit managers from “gaming the system”

PhRMA

People around the country say they are paying too much for their prescription medicines. State policymakers could help address this problem now. Doing so starts with stopping pharmacy benefit managers (PBMs) from taking advantage of the health system and patients.

Insurance 210
article thumbnail

Triple-Combination, Fixed-Dose Acne Gel Shows Promise as Treatment

Drug Topics

The once-daily, triple-combination gel led to a marked reduction in moderate to severe acne.

187
187
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Amazon closes $3.9B One Medical deal as its builds out its healthcare strategy

Fierce Healthcare

Amazon closes $3.

130
130
article thumbnail

Opinion: Fixing U.S. public health will require a health-systems revolution — and for physicians to take a backseat

STAT

A classic warning in public health goes like this: “A society that spends so much on health care that it cannot or will not spend adequately on other health enhancing activities may actually be reducing the health of its population.” No nation is as guilty of this practice as the United States, with its extremely high health expenditures alongside abysmal population-level health outcomes.

126
126
article thumbnail

CVS Health investing $11M in affordable housing for Detroit

Drug Store News

The affordable project in Brush Park will feature 53 units, with many as low as 30% AMI or below.

124
124
article thumbnail

Increase Seen in Eczema, Prevalence Varies by Race and Ethnicity

Drug Topics

Previous surveys suggested care disparities. Investigators compared these outcomes because of a lack of research in this space.

187
187
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Optum report: Alzheimer's drugs key for payers to watch in Q1

Fierce Healthcare

Optum report: Alzheimer's drugs key for payers to watch in Q1 pminemyer Fri, 02/24/2023 - 16:18

129
129
article thumbnail

Shining a light on Raman for microbiological analysis

European Pharmaceutical Review

Advances with microbiological methods are providing more accurate and sensitive datasets at a faster rate, relating to bacterial identity, numbers, responses to environments and so on. Recent years have seen progress with applying a long-established spectrophotometric phenomenon – Raman spectra – to advance our understanding of bacterial populations, including differentiating between living and dead cells and interpreting phenotypic variations to different environmental stressors.

Labelling 121
article thumbnail

Opinion: Needed: a new framework to make sure health companies play fair with patient data

STAT

As a health policy wonk and health economist who has worked in pharmaceutical companies in the United States, Latin America, and Europe, I’ve seen vast volumes of data generated, gathered, aggregated, analyzed, shared, and resold by health care companies and organizations. In my studies with the world’s top medical statistics experts at the University of Oxford’s Centre for Evidence Based Medicine, I’ve also seen how flawed many datasets are, missing critical data pie

article thumbnail

Recommendations Differ Between WHO and CDC for HPV Vaccine Schedules

Drug Topics

The World Health Organization (WHO) and the CDC recommend different doses when it comes to vaccine protection against the human papillomavirus (HPV).

Vaccines 187
article thumbnail

Hospital lobby urges FTC to withdraw or add healthcare exceptions to sweeping noncompete ban

Fierce Healthcare

Hospital lobby urges FTC to withdraw or add healthcare exceptions to sweeping noncompete ban dmuoio Wed, 02/22/2023 - 15:55

Hospitals 124
article thumbnail

Merck's COVID pill Lagevrio takes another hit with thumbs-down from EU regulator

Fierce Pharma

Merck's COVID pill Lagevrio takes another hit with thumbs-down from EU regulator kdunleavy Fri, 02/24/2023 - 09:38

116
116
article thumbnail

Amid fentanyl crisis, first-of-its-kind study to evaluate expanded methadone access

STAT

Ever since fentanyl entered the U.S. drug supply, many Americans seeking treatment for opioid addiction have found that only a single medication is effective at easing cravings and withdrawal: methadone. But even though the drug is widely considered to be safe and effective, there’s not much data about how methadone stacks up against its main alternative, buprenorphine.

119
119
article thumbnail

Moderna Plans to Offer Free COVID-19 Vaccine to Uninsured Patients

Drug Topics

More traditional health care coverage will begin when the U.S. public health emergency response to COVID-19 ends on May 11.

Vaccines 187
article thumbnail

Humana to shed employer group commercial business

Fierce Healthcare

Humana to shed employer group commercial business pminemyer Thu, 02/23/2023 - 11:23

119
119
article thumbnail

GenScript ProBio and RVAC partner for Covid-19 vaccine pDNA

Pharmaceutical Technology

GenScript ProBio has announced a strategic collaboration with RVAC Medicines to manufacture GMP-grade plasmid DNA (pDNA) for the latter’s RVM-V001, an mRNA Covid-19 vaccine candidate. Under the agreement, GenScript ProBio will offer GMP plasmid manufacturing service for the RVM-V001 programme. This collaboration is expected to help expedite the clinical manufacturing of RVM-V001 and future mRNA-based vaccines that target infectious diseases such as Clostriodioides difficile infection (CDI) and R

Vaccines 115
article thumbnail

Tools to predict stroke risk work less well for Black patients, study finds

STAT

Stroke risk prediction tools are meant to guide how doctors approach a potentially deadly condition, using factors like heart disease and high blood pressure to get a handle on which patients might benefit from a particular treatment. For years, doctors have used several different algorithms to try to capture the true risk of stroke, including newer models that use machine learning.

Hospitals 115
article thumbnail

Young Children Benefit from 3 Doses of Pfizer-BioNTech COVID-19 Vaccine

Drug Topics

The vaccine was 73.2% effective in children aged 6 months to 4 years when administered during the Omicron-dominant phase.

Vaccines 187
article thumbnail

Costly discharge delays highlight need for more downstream care options, New York group's analysis shows

Fierce Healthcare

Costly discharge delays highlight need for more downstream care options, New York group's analysis shows dmuoio Wed, 02/22/2023 - 12:48

119
119
article thumbnail

European Pharmaceutical Review Issue 1 2023

European Pharmaceutical Review

Included in this issue of European Pharmaceutical Review : FOREWORD Accelerating drug development David Elder, David P Elder Consultancy RAMAN SPECTROSCOPY Shining a light on Raman for microbiological analysis Tim Sandle, Bio Products Laboratory LIMS Overcoming barriers to capturing data in a laboratory Samantha Kanza, University of Southampton ENVIRONMENTAL MONITORING Endotoxin trends: sustainability, automation and beyond Miriam Guest, AstraZeneca UK REGULATORY INSIGHT UPC opt-out – a strateg

111
111
article thumbnail

STAT+: Moderna expands CRISPR gene editing research with ElevateBio partnership

STAT

Moderna is aiming to build a gene editing franchise powered by some of the same technologies used in its COVID-19 vaccines. The Cambridge biotech company announced Wednesday that it will partner with Life Edit Therapeutics to develop potentially permanent treatments for rare genetic diseases and other conditions. Life Edit is the North Carolina subsidiary of ElevateBio, a cell and gene therapy manufacturing firm in Waltham.

Vaccines 112